Voyager Therapeutics (VYGR) Invested Capital (2014 - 2026)
Voyager Therapeutics recorded quarterly Invested Capital of $173.7 million in Q1 2026, down 11.43% quarter-over-quarter from $196.1 million in Q4 2025, and down 36.32% year-over-year from $272.7 million in Q1 2025.
Voyager Therapeutics' Invested Capital history runs 13 years deep, the most recent figure standing at $173.7 million for Q1 2026.
- In Q1 2026, Invested Capital fell 36.32% year-over-year to $173.7 million; the TTM figure through Mar 2026 stood at $173.7 million (down 36.32% YoY), while the FY2025 annual figure was $196.1 million, down 34.59% from the prior year.
- Invested Capital came in at $173.7 million for Q1 2026 at Voyager Therapeutics, down from $196.1 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $340.9 million in Q1 2024 to a low of $59.0 million in Q4 2022.
- A 5-year average of $206.8 million and a median of $217.0 million in 2023 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital slumped 45.67% in 2022 and soared 300.41% in 2023, its largest moves.
- Voyager Therapeutics' Invested Capital stood at $59.0 million in 2022, then jumped by 300.41% to $236.3 million in 2023, then climbed by 26.84% to $299.8 million in 2024, then sank by 34.59% to $196.1 million in 2025, then declined by 11.43% to $173.7 million in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $173.7 million, $196.1 million, and $219.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - | 173.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173.67 Mn |
| Dec 31, 2025 | 196.08 Mn |
| Sep 30, 2025 | 219.83 Mn |
| Jun 30, 2025 | 243.94 Mn |
| Mar 31, 2025 | 272.70 Mn |
| Dec 31, 2024 | 299.76 Mn |
| Sep 30, 2024 | 330.31 Mn |
| Jun 30, 2024 | 335.42 Mn |
| Mar 31, 2024 | 340.89 Mn |
| Dec 31, 2023 | 236.32 Mn |
| Sep 30, 2023 | 176.22 Mn |
| Jun 30, 2023 | 199.03 Mn |
| Mar 31, 2023 | 216.96 Mn |
| Dec 31, 2022 | 59.02 Mn |
| Sep 30, 2022 | 79.82 Mn |
| Jun 30, 2022 | 60.05 Mn |
| Mar 31, 2022 | 75.93 Mn |
| Dec 31, 2021 | 95.06 Mn |
| Sep 30, 2021 | 87.42 Mn |
| Jun 30, 2021 | 110.54 Mn |
| Mar 31, 2021 | 136.21 Mn |
| Dec 31, 2020 | 154.32 Mn |
| Sep 30, 2020 | 166.24 Mn |
| Jun 30, 2020 | 76.88 Mn |
| Mar 31, 2020 | 79.76 Mn |
| Dec 31, 2019 | 99.51 Mn |
| Sep 30, 2019 | 108.16 Mn |
| Jun 30, 2019 | 118.40 Mn |
| Mar 31, 2019 | 100.69 Mn |
| Dec 31, 2018 | 46.45 Mn |
| Sep 30, 2018 | 65.59 Mn |
| Jun 30, 2018 | 81.97 Mn |
| Mar 31, 2018 | 98.29 Mn |
| Dec 31, 2017 | 134.05 Mn |
| Sep 30, 2017 | 85.21 Mn |
| Jun 30, 2017 | 105.29 Mn |
| Mar 31, 2017 | 122.70 Mn |
| Dec 31, 2016 | 135.92 Mn |
| Sep 30, 2016 | 149.12 Mn |
| Jun 30, 2016 | 155.70 Mn |
| Mar 31, 2016 | 163.60 Mn |
| Dec 31, 2015 | 169.07 Mn |
| Sep 30, 2015 | -47.14 Mn |
| Dec 31, 2014 | -20.83 Mn |